Health law, patient law 86.66




  •  Title: Medisch Recht trans
Author:  KULeuven
  •  Title: European Association of Health Law trans
Description:  The European Association of Health Law was established in 2007 by a group of health lawyers in academic institutions from around Europe to provide a forum for health lawyers from countries in the Council of Europe and beyond to discuss and collaborate on issues of importance in the development of health law and related policies. This initiative is unique in that it is the only association of health lawyers that focuses on the contributions of Europe; it, thus, adds considerable value to the national and international bodies in this area. The Mission Statement of the EAHL is “to strengthen the health and human rights interface throughout Europe, and to serve as an indispensable source of advice and guidance for the future of health law and policies in Europe.
  •  Title: Patient Rights in the EU trans
Author:  Katholieke Universiteit Leuven
  •  Title: BIG-register trans
  •  Title: Bundesministerium für Gesundheit trans
  •  Title: WHO - World Health Organization trans
  •  Title: Patients' Rights Laws in Europe trans
  •  Title: European Centre for Advanced Legal Studies in Healthcare trans
  •  Title: Gezondheidsrecht trans
Author:  Recht.nl
  •  Title: Publicaties sectie Gezondheidsrecht trans
Author:  Instituut Beleid en Management Gezondheidszorg Erasmus Universiteit
  •  Title: Protection of persons in medical research: The netherlands trans
Author:  Hondius, E.H.
Source:  Universiteit Utrecht
Published in:  Netherlands reports to the fifteenth international Congress of comparative law, II.A.4, p. 155-161
Year:  1998
Description:  90-5095-041-8, conference report
Abstract:  On 19 March 1998, the Utrecht University Hospital (Academisch Ziekenhuis Utrecht) announced that in 1996 an international experiment with an anticoagulation drug had been halted after the death of seventeen patients. In the experiment, 1,316 patients participated, 665 of whom received aspirin to reduce the risk of a new stroke. The other 651 patients received the anticoagulation drug which aimed at preventing coagulation in the brain. Of the latter group, 53 patients had serious hemorrages and seventeen died. In the aspirin group six patients had similar complications and one died. The research team supposes that the anti-coagulation drug has diluted the blood too much, so it could leak away through damaged vascular walls. The experiment had been examined and approved by the medical ethical commissions of all 58 participating hospitals. After the first experiment was stopped, a new experiment with an adapted anti-coagulation drug was started, again after the approval of the 58 hospitals concerned. So far, only 135 patients – out of 4,500 needed – have agreed to participate.
  •  Title: Premarket Approvals trans
Author:  Center for Devices and Radiological Health
  •  Title: DMOZ: opden directory project: Top: World: Nederlands: Maatschappij: Recht: Gezondheidsrecht trans
Author:  Universiteit van Tilburg
  •  Title: US Department of Health and Human Services: National Institutes of Health trans
  •  Title: Department of Health UK trans
  •  Title: New Jersey Law Network Health Law trans
  •  Title: New Jersey Law Network Disability Law trans
  •  Title: Wet- en regelgeving trans
Author:  Centrum voor Ethiek en Gezondheid (ceg)
  •  Title: Health Law resource trans
  •  Title: Transgender law & Policy Institute trans
Description:  Transgender Law and Policy Institute is a non-profit organization dedicated to engaging in effective advocacy for transgender people in our society. The TLPI brings experts and advocates together to work on law and policy initiatives designed to advance transgender equality.